SYRS
Vanguard Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-268,154
| Closed | -$61.7K | – | 4312 |
|
2024
Q4 | $61.7K | Sell |
268,154
-685,159
| -72% | -$158K | ﹤0.01% | 4197 |
|
2024
Q3 | $2.05M | Sell |
953,313
-14,904
| -2% | -$32K | ﹤0.01% | 3551 |
|
2024
Q2 | $5M | Buy |
968,217
+40,171
| +4% | +$207K | ﹤0.01% | 3264 |
|
2024
Q1 | $4.97M | Buy |
928,046
+163,234
| +21% | +$873K | ﹤0.01% | 3304 |
|
2023
Q4 | $5.96M | Buy |
764,812
+236,620
| +45% | +$1.84M | ﹤0.01% | 3210 |
|
2023
Q3 | $2.09M | Buy |
528,192
+30,984
| +6% | +$122K | ﹤0.01% | 3566 |
|
2023
Q2 | $1.57M | Buy |
497,208
+9,986
| +2% | +$31.5K | ﹤0.01% | 3745 |
|
2023
Q1 | $1.3M | Buy |
487,222
+14,492
| +3% | +$38.7K | ﹤0.01% | 3834 |
|
2022
Q4 | $1.7M | Sell |
472,730
-14,803
| -3% | -$53.1K | ﹤0.01% | 3721 |
|
2022
Q3 | $3.14M | Sell |
487,533
-2,395,075
| -83% | -$15.4M | ﹤0.01% | 3563 |
|
2022
Q2 | $2.78M | Buy |
2,882,608
+627,078
| +28% | +$604K | ﹤0.01% | 3664 |
|
2022
Q1 | $2.69M | Sell |
2,255,530
-534,843
| -19% | -$637K | ﹤0.01% | 3829 |
|
2021
Q4 | $9.1M | Sell |
2,790,373
-195,605
| -7% | -$638K | ﹤0.01% | 3276 |
|
2021
Q3 | $13.3M | Buy |
2,985,978
+210,402
| +8% | +$941K | ﹤0.01% | 3082 |
|
2021
Q2 | $15.1M | Buy |
2,775,576
+43,152
| +2% | +$235K | ﹤0.01% | 2991 |
|
2021
Q1 | $20.4M | Buy |
2,732,424
+687,720
| +34% | +$5.14M | ﹤0.01% | 2775 |
|
2020
Q4 | $22.2M | Buy |
2,044,704
+11,281
| +0.6% | +$122K | ﹤0.01% | 2587 |
|
2020
Q3 | $18M | Buy |
2,033,423
+132,050
| +7% | +$1.17M | ﹤0.01% | 2515 |
|
2020
Q2 | $20.3M | Buy |
1,901,373
+103,005
| +6% | +$1.1M | ﹤0.01% | 2420 |
|
2020
Q1 | $10.7M | Buy |
1,798,368
+1,266
| +0.1% | +$7.51K | ﹤0.01% | 2587 |
|
2019
Q4 | $12.4M | Buy |
1,797,102
+1,408
| +0.1% | +$9.73K | ﹤0.01% | 2753 |
|
2019
Q3 | $18.6M | Buy |
1,795,694
+30,684
| +2% | +$318K | ﹤0.01% | 2522 |
|
2019
Q2 | $16.3M | Buy |
1,765,010
+863,074
| +96% | +$7.99M | ﹤0.01% | 2615 |
|
2019
Q1 | $8.24M | Buy |
901,936
+221,796
| +33% | +$2.03M | ﹤0.01% | 2925 |
|
2018
Q4 | $3.79M | Sell |
680,140
-364,799
| -35% | -$2.03M | ﹤0.01% | 3179 |
|
2018
Q3 | $12.4M | Buy |
1,044,939
+43,562
| +4% | +$519K | ﹤0.01% | 2808 |
|
2018
Q2 | $10.2M | Buy |
1,001,377
+82,116
| +9% | +$838K | ﹤0.01% | 2894 |
|
2018
Q1 | $11.9M | Buy |
919,261
+336,762
| +58% | +$4.37M | ﹤0.01% | 2739 |
|
2017
Q4 | $5.67M | Buy |
582,499
+32,515
| +6% | +$316K | ﹤0.01% | 3083 |
|
2017
Q3 | $8.1M | Buy |
549,984
+167,381
| +44% | +$2.46M | ﹤0.01% | 2910 |
|
2017
Q2 | $6.16M | Buy |
382,603
+250,507
| +190% | +$4.03M | ﹤0.01% | 3010 |
|
2017
Q1 | $2.1M | Buy |
132,096
+96,729
| +274% | +$1.54M | ﹤0.01% | 3367 |
|
2016
Q4 | $430K | Buy |
35,367
+19,940
| +129% | +$242K | ﹤0.01% | 3761 |
|
2016
Q3 | $214K | Buy |
+15,427
| New | +$214K | ﹤0.01% | 3891 |
|